相关实验视频
Updated: Jun 9, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
38
性结肠炎的管理:我们在哪里,我们在走向哪里?
Adnan Abbas1, David M P Di Fonzo2, Panu Wetwittayakhlang1,3
1Division of Gastroenterology and Hepatology, Department of Medicine, McGill University, Health Centre, Montreal, Canada.
Expert review of gastroenterology & hepatology
|October 29, 2024
概括
由于疾病的复杂性,在性结肠炎 (UC) 中实现缓解是具有挑战性的. 个性化医疗,根据个体患者的个人资料量身定制治疗,为改善缓解率和优化护理提供了一个有希望的策略.
科学领域:
- 胃肠道学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 性结肠炎 (UC) 呈现出显著的异质性,导致缓解率低,尽管治疗方面取得了进展.
- 目前对UC的诊断和治疗工具的有效性低于最佳,除了药物安全问题和对新疗法的有限获取.
研究的目的:
- 审查目前对性结肠炎 (UC) 的治疗目标.
- 评估各种疗法和管理策略在实现缓解方面的有效性.
- 探索个性化医疗在改善UC缓解率方面的作用.
主要方法:
- 目前性结肠炎 (UC) 治疗策略的文献综述.
- 基于临床,遗传和免疫学预测因素的个性化医疗方法的评估.
- 对实施个性化UC管理模型的挑战和解决方案的分析.
主要成果:
- 个性化医疗,将治疗量身定制到个体患者的个人资料,显示了改善UC缓解率的希望.
- 解决疾病异质性和个体特征对于有效的UC管理至关重要.
- 讨论了适应个性化管理模式的可行性和潜在的实施策略.
结论:
- 生物制剂,小分子和数字健康解决方案的持续开发对于推进UC护理至关重要.
- 非侵入性监测技术和个性化的分层方法是优化患者结果和降低医疗保健成本的关键.
- 个性化管理策略对于解决性结肠炎 (UC) 的未满足需求至关重要.
更多相关视频
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Inflammatory Bowel Disease V: Surgical Management
125
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
125
Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74

